Loading viewer...
investor_presentation
Format: PDF investor_presentation
L'Oréal investor presentation dated July 2019.
31 July 20192019 half -year results31 July 20192019 half -year results
Chief Financial OfficerH1-2018 H1-2019€14.81Bn
31 July 2019 3Consolidated sales at the end of June 2019
€13.39 BnLike for like growth +7.3%
−external growth impact +1.1%
Growth at constant exchange rates +8.4%
−exchange rate impact +2.2%
Reported growth +10.6%31 July 2019 4Changes in exchange rates
consolidated sales at
30 June 2019Average rate
US Dollar (1 € =) 23.8% 1.210 1.130 +7.1%
Chinese Yuan 13.1% 0.130 0.130 +0.5%
Sterling Pound 4.0% 1.137 1.145 +0.7%
Russian Ruble 2.4% 0.014 0.014 -2.4%
Canadian Dollar 2.3% 0.647 0.664 +2.7%
Brazilian Real 2.1% 0.242 0.230 -4.7%
Japanese Yen (1000) 1.7% 7.601 8.046 +5.8%
Korean Won (1000) 1.5% 0.768 0.773 +0.6%
Mexican peso 1.5% 0.043 0.046 +6.5%31 July 2019 5Consolidated sales by division at the end of June 2019
H1-2018 H1-2019 Like-for-likeAt constant
exchange rateReported
Professional Products 1 631.5 1 714.2 +2.5% +2.6% +5.1%
Consumer Products 6 136.8 6 530.5 +3.1% +5.0% +6.4%
L'Oréal Luxe 4 391.4 5 150.1 +13.2% +13.6% +17.3%
Active Cosmetics 1 231.0 1 416.7 +13.6% +14.2% +15.1%
Total 13390.7 14 811.5 +7.3% +8.4% +10.6%31 July 2019 6Total sales by region at the end of June 2019
H1-2018 H1-2019 Like-for-like Reported
Western Europe 4 134.1 4 212.6 +1.0% +1.9%
North America 3 564.4 3 805.7 0.0% +6.8%
New Markets 5 692.2 6 793.1 +16.6% +19.3%
Preview truncated — download the full document for the complete content.
conference
37 Pages
investor_presentation
16 Pages
Vertex Pharmaceuticals